Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large

Experimental Gerontology

Volumn 42, Issue 11, 2007, Pages 1116-1122

  Mooijaart, Simon P ^a   Koeijvoets, Kristel M C ^b   Sijbrands, Eric J G ^b   Daha, Mohamed R ^a   Westendorp, Rudi G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aging; C reactive protein; Interleukin 6; Mortality; Vision

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT FACTOR H; INTERLEUKIN 6;

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMPLEMENT FACTOR H; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LONGITUDINAL STUDIES; MACULAR DEGENERATION; MALE; NETHERLANDS; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; VISUAL ACUITY;

EID: 35448973312     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2007.08.001     Document Type: Article

References (34)

1. Bootsma-van der Wiel A., van Exel E., de Craen A.J., Gussekloo J., Lagaay A.M., Knook D.L., and Westendorp R.G. A high response is not essential to prevent selection bias: results from the Leiden 85-plus study. J. Clin. Epidemiol. 55 11 (2002) 1119-1125
2. Despriet D.D., Klaver C.C., Witteman J.C., Bergen A.A., Kardys I., de Maat M.P., Boekhoorn S.S., Vingerling J.R., Hofman A., Oostra B.A., Uitterlinden A.G., Stijnen T., van Duijn C.M., and de Jong P.T. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 296 3 (2006) 301-309
3. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 5720 (2005) 421-424
4. Friese M.A., Hellwage J., Jokiranta T.S., Meri S., Peter H.H., Eibel H., and Zipfel P.F. FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol. Immunol. 36 13-14 (1999) 809-818
5. Giannakis E., Jokiranta T.S., Male D.A., Ranganathan S., Ormsby R.J., Fischetti V.A., Mold C., and Gordon D.L. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur. J. Immunol. 33 4 (2003) 962-969
6. Goverdhan S.V., Lotery A.J., Cree A.J., and Ye S. Complement factor H Y402H gene polymorphism in coronary artery disease and atherosclerosis. Atherosclerosis 188 1 (2006) 213-214
7. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., and Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102 20 (2005) 7227-7232
8. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., and Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 5720 (2005) 419-421
9. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger Jr. W.H., Heimovitz H., Cohen H.J., and Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106 5 (1999) 506-512
10. Heijmans B.T., Gussekloo J., Kluft C., Droog S., Lagaay A.M., Knook D.L., Westendorp R.G., and Slagboom E.P. Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene (MTHFR). Eur. J. Hum. Genet. 7 2 (1999) 197-204
11. Kardys I., Klaver C.C., Despriet D.D., Bergen A.A., Uitterlinden A.G., Hofman A., Oostra B.A., van Duijn C.M., de Jong P.T., and Witteman J.C. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J. Am. Coll. Cardiol. 47 8 (2006) 1568-1575
12. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 5720 (2005) 385-389
13. Laine M., Jarva H., Seitsonen S., Haapasalo K., Lehtinen M.J., Lindeman N., Anderson D.H., Johnson P.T., Jarvela I., Jokiranta T.S., Hageman G.S., Immonen I., and Meri S. Abstract Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J. Immunol. 15 178(6) (2007) 3831-3836
14. Lusis A.J. Atherosclerosis. Nature 407 6801 (2000) 233-241
15. Magnusson K.P., Duan S., Sigurdsson H., Petursson H., Yang Z., Zhao Y., Bernstein P.S., Ge J., Jonasson F., Stefansson E., Helgadottir G., Zabriskie N.A., Jonsson T., Bjornsson A., Thorlacius T., Jonsson P.V., Thorleifsson G., Kong A., Stefansson H., Zhang K., Stefansson K., and Gulcher J.R. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med. 3 1 (2005) e5
16. McGeer E.G., Klegeris A., and McGeer P.L. Inflammation, the complement system and the diseases of aging. Neurobiol. Aging 26 Suppl 1 (2005) 94-97
17. Mold C., Kingzette M., and Gewurz H. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. J. Immunol. 133 2 (1984) 882-885
18. Nicaud V., Francomme C., Ruidavets J.B., Luc G., Arveiler D., Kee F., Evans A., Morrison C., Blankenberg S., Cambien F., and Tiret L. Lack of association between complement factor H polymorphisms and coronary artery disease or myocardial infarction. J. Mol. Med. (2007)
19. Oksjoki R., Kovanen P.T., and Pentikainen M.O. Role of complement activation in atherosclerosis. Curr. Opin. Lipidol. 14 5 (2003) 477-482
20. Pai J.K., Manson J.E., Rexrode K.M., Albert C.M., Hunter D.J., and Rimm E.B. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. Eur. Heart J. (2007)
21. Rodriguez D.C., Esparza-Gordillo J., Goicoechea D.J., Lopez-Trascasa M., and Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41 4 (2004) 355-367
22. Seddon J.M., Francis P.J., George S., Schultz D.W., Rosner B., and Klein M.L. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297 16 (2007) 1793-1800
23. Skerka C., Lauer N., Weinberger A.A., Keilhauer C.N., Suhnel J., Smith R., Schlotzer-Schrehardt U., Fritsche L., Heinen S., Hartmann A., Weber B.H., and Zipfel P.F. Defective complement control of Factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol. Immunol. 44 13 (2007) 3398-3406
24. Stark K., Neureuther K., Sedlacek K., Hengstenberg W., Fischer M., Baessler A., Wiedmann S., Jeron A., Holmer S., Erdmann J., Schunkert H., and Hengstenberg C. Common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Clin. Sci. (Lond.) (2007)
25. Takabayashi T., Vannier E., Burke J.F., Tompkins R.G., Gelfand J.A., and Clark B.D. Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells. J. Infect. Dis. 177 6 (1998) 1622-1628
26. Takabayashi T., Vannier E., Clark B.D., Margolis N.H., Dinarello C.A., Burke J.F., and Gelfand J.A. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J. Immunol. 156 9 (1996) 3455-3460
27. Thakkinstian A., Han P., McEvoy M., Smith W., Hoh J., Magnusson K., Zhang K., and Attia J. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum. Mol. Genet. 15 18 (2006) 2784-2790
28. van Bemmel T., Gussekloo J., Westendorp R.G., and Blauw G.J. In a population-based prospective study, no association between high blood pressure and mortality after age 85 years. J. Hypertens. 24 2 (2006) 287-292
29. van den Biggelaar A.H., Huizinga T.W., de Craen A.J., Gussekloo J., Heijmans B.T., Frolich M., and Westendorp R.G. Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp. Gerontol. 39 9 (2004) 1407-1414
30. van der Linden M.W., Huizinga T.W., Stoeken D.J., Sturk A., and Westendorp R.G. Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J. Immunol. Methods 218 1-2 (1998) 63-71
31. van Leeuwen R., Ikram M.K., Vingerling J.R., Witteman J.C., Hofman A., and de Jong P.T. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol. Vis. Sci. 44 9 (2003) 3771-3777
32. van Leeuwen R., Klaver C.C., Vingerling J.R., Hofman A., and de Jong P.T. Epidemiology of age-related maculopathy: a review. Eur. J. Epidemiol. 18 9 (2003) 845-854
33. Weverling-Rijnsburger A.W., Blauw G.J., Lagaay A.M., Knook D.L., Meinders A.E., and Westendorp R.G. Total cholesterol and risk of mortality in the oldest old. Lancet 350 9085 (1997) 1119-1123
34. Zee R.Y., Diehl K.A., and Ridker P.M. Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis (2005)